As of 4:00pm ET
| -0.30 / -2.11%|
The 11 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 22.00 and a low estimate of 12.00. The median estimate represents a +21.86% increase from the last price of 13.95.
The current consensus among 12 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.